Combination therapy for pulmonary arterial hypertension: still more questions than answers

被引：24

作者：

Hoeper, MM

Dinh-Xuan, AT

机构：

[1] Hannover Med Sch, Dept Resp Med, D-30625 Hannover, Germany

[2] Univ Paris 05, CHU Cochin Port Royal, Assistance Publ Hop Paris, Serv Physiol Explorat Fonctionnelles, Paris, France

来源：

EUROPEAN RESPIRATORY JOURNAL | 2004年 / 24卷 / 03期

关键词：

D O I：

10.1183/09031936.04.00072104

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：339 / 340

页数：2

共 19 条

[1] Sitaxsentan therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

Langleben, D ;

Frost, A ;

Horn, EM ;

Oudiz, R ;

Shapiro, S ;

McLaughlin, V ;

Hill, N ;

Tapson, VF ;

Robbins, IM ;

Zwicke, D ;

Duncan, B ;

Dixon, RAF ;

Frumkin, LR .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) :441-447

[2] Beraprost therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

McLaughlin, V ;

Tapson, V ;

Oudiz, R ;

Shapiro, S ;

Robbins, IM ;

Channick, R ;

Badesch, D ;

Rayburn, BK ;

Flinchbaugh, R ;

Sigman, J ;

Arneson, C ;

Jeffs, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125

[3] Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study [J].

Channick, RN ;

Simonneau, G ;

Sitbon, O ;

Robbins, IM ;

Frost, A ;

Tapson, VF ;

Badesch, DB ;

Roux, S ;

Rainisio, M ;

Bodin, F ;

Rubin, LJ .

LANCET, 2001, 358 (9288) :1119-1123

[4] AN IMBALANCE BETWEEN THE EXCRETION OF THROMBOXANE AND PROSTACYCLIN METABOLITES IN PULMONARY-HYPERTENSION [J].

CHRISTMAN, BW ;

MCPHERSON, CD ;

NEWMAN, JH ;

KING, GA ;

BERNARD, GR ;

GROVES, BM ;

LOYD, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :70-75

[5]

DINHXUAN AT, 1992, EUR RESPIR J, V5, P757

[6] Pathobiology of pulmonary arterial hypertension [J].

Eddahibi, S ;

Morrell, N ;

D'Ortho, MP ;

Naeije, R ;

Adnot, S .

EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (06) :1559-1572

[7] Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension:: With pulmonary arterial hypertension:: A randomized, double-blind, placebo-controlled trial [J].

Galiè, N ;

Humbert, M ;

Vachiéry, JL ;

Vizza, CD ;

Kneussl, M ;

Manes, A ;

Sitbon, O ;

Torbicki, A ;

Delcroix, M ;

Naeije, R ;

Hoeper, M ;

Chaouat, A ;

Morand, S ;

Besse, B ;

Simonneau, G .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (09) :1496-1502

[8] The new clinical trials on pharmacological treatment in pulmonary arterial hypertension [J].

Galiè, N ;

Manes, A ;

Branzi, A .

EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (04) :1037-1049

[9] Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension [J].

Ghofrani, HA ;

Rose, F ;

Schermuly, RT ;

Olschewski, H ;

Wiedemann, R ;

Kreckel, A ;

Weissmann, N ;

Ghofrani, S ;

Enke, B ;

Seeger, W ;

Grimminger, F .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) :158-164

[10] Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids [J].

Hoeper, MM ;

Taha, N ;

Bekjarova, A ;

Gatzke, R ;

Spiekerkoetter, E .

EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) :330-334

← 1 2 →